logo

Spectrum Pharmaceuticals Inc (SPPI)



Trade SPPI now with
  Date
  Headline
10/4/2019 7:04:29 AM Spectrum Reports Publication Of Positive Poziotinib Data In Cancer Cell
7/22/2019 7:08:10 AM Spectrum Pharmaceuticals Further Expands Poziotinib Clinical Program
6/2/2019 9:12:55 AM Spectrum Pharma Announces Integrated Results From Two Phase 3 ROLONTIS Trials Being Presented At ASCO Annual Meeting
3/15/2019 7:01:27 AM Spectrum Pharma Provides BLA Filing Update For ROLONTIS
1/17/2019 7:46:33 AM Spectrum Pharma Sells Marketed Portfolio To Acrotech Biopharma
12/27/2018 7:03:24 AM Spectrum Submits BLA To FDA For ROLONTIS As Treatment For Chemotherapy-Induced Neutropenia
12/6/2018 7:08:45 AM Spectrum Pharma Says Results From RECOVER Phase 3 Study Of ROLONTIS At 2018 SABCS Annual Meeting
12/3/2018 7:45:32 AM Spectrum Reports Positive Results From Phase 2 Trial Evaluating Use Of Oral Leucovorin
11/13/2018 7:03:00 AM Spectrum Appoints Jeffrey Vacirca To Its Board
10/23/2018 7:05:36 AM Spectrum Pharma Gets FDA Approval Of KHAPZORY For Injection
10/18/2018 7:04:04 AM Spectrum Pharmaceuticals Appoints Francois Lebel As Chief Medical Officer
9/12/2018 7:07:55 AM Spectrum Expands Poziotinib Clinical Trial Into First-Line Therapy And Doses First Patient
6/29/2018 7:08:55 AM Spectrum Pharma Presents ADVANCE Phase 3 ROLONTIS (eflapegrastim) Data At MASCC 2018
  
 
>